Total Payments
$6,126
2024 Payments
$438.60
Companies
37
Transactions
241
Medicare Patients
2,871
Medicare Billing
$557,520
Payment Breakdown by Category
Food & Beverage$6,121 (99.9%)
Education$5.11 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,121 | 240 | 99.9% |
| Education | $5.11 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $1,161 | 7 | $0 (2023) |
| ABBVIE INC. | $864.58 | 45 | $0 (2024) |
| Novo Nordisk Inc | $671.37 | 36 | $0 (2021) |
| Amgen Inc. | $367.17 | 15 | $0 (2024) |
| Lilly USA, LLC | $350.60 | 15 | $0 (2024) |
| Incyte Corporation | $225.71 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $185.23 | 13 | $0 (2019) |
| Galderma Laboratories, L.P. | $178.68 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $170.83 | 8 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $165.02 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.60 | 21 | ABBVIE INC. ($142.83) |
| 2023 | $586.30 | 20 | AbbVie Inc. ($163.41) |
| 2022 | $381.04 | 14 | Incyte Corporation ($116.64) |
| 2021 | $518.04 | 12 | MERZ NORTH AMERICA, INC. ($250.00) |
| 2020 | $192.72 | 7 | AbbVie Inc. ($178.13) |
| 2019 | $1,061 | 43 | Merz North America, Inc. ($258.53) |
| 2018 | $1,622 | 60 | Merz North America, Inc. ($500.00) |
| 2017 | $1,326 | 64 | Novo Nordisk Inc ($265.60) |
All Payment Transactions
241 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.57 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $3.45 | General |
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Immunology | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Immunology | ||||||
| 07/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.57 | General |
| Category: Immunology | ||||||
| 07/02/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $28.05 | General |
| 06/28/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Immunology | ||||||
| 06/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.11 | General |
| 05/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Inflammation | ||||||
| 03/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.98 | General |
| 02/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $35.01 | General |
| Category: Dermatology | ||||||
| 02/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Dermatology | ||||||
| 02/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.87 | General |
| 02/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Immunology | ||||||
| 12/20/2023 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $14.82 | General |
| 12/09/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $19.35 | General |
| 10/18/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $4.55 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 804 | 1,248 | $603,975 | $149,204 |
| 2022 | 15 | 878 | 1,426 | $553,219 | $137,600 |
| 2021 | 12 | 485 | 661 | $468,501 | $118,328 |
| 2020 | 17 | 704 | 996 | $781,539 | $152,388 |
Total Patients
2,871
Total Services
4,331
Medicare Billing
$557,520
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2023 | 43 | 69 | $195,678 | $52,054 | 26.6% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 22 | 32 | $122,088 | $32,435 | 26.6% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 108 | 111 | $60,430 | $14,854 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 167 | 233 | $61,239 | $13,854 | 22.6% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 58 | 92 | $31,664 | $8,244 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 93 | $34,678 | $7,889 | 22.7% |
| 37766 | Removal of varicose veins of arm or leg, more than 20 incisions | Office | 2023 | 13 | 17 | $24,462 | $3,656 | 14.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 68 | 93 | $18,216 | $3,627 | 19.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $14,264 | $2,985 | 20.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 30 | 34 | $11,254 | $2,511 | 22.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 27 | 29 | $8,589 | $1,826 | 21.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 40 | $6,581 | $1,558 | 23.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 48 | 307 | $5,998 | $1,483 | 24.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $4,413 | $1,086 | 24.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 16 | 16 | $2,612 | $672.74 | 25.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 26 | $1,811 | $468.78 | 25.9% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2022 | 38 | 55 | $166,137 | $43,618 | 26.3% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2022 | 16 | 19 | $76,707 | $20,432 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 271 | $72,731 | $16,740 | 23.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 112 | 113 | $63,566 | $15,565 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 110 | $41,725 | $9,717 | 23.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 52 | 79 | $28,184 | $6,998 | 24.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 85 | 130 | $25,830 | $5,511 | 21.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 66 | 66 | $21,786 | $5,209 | 23.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 38 | 43 | $14,435 | $3,513 | 24.3% |
About Dr. Eric Dohner, MD
Dr. Eric Dohner, MD is a Family Medicine healthcare provider based in Walton, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801869821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Dohner, MD has received a total of $6,126 in payments from pharmaceutical and medical device companies, with $438.60 received in 2024. These payments were reported across 241 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,121).
As a Medicare-enrolled provider, Dohner has provided services to 2,871 Medicare beneficiaries, totaling 4,331 services with total Medicare billing of $557,520. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Phlebology
- Location Walton, NY
- Active Since 02/09/2006
- Last Updated 10/26/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801869821
Products in Payments
- XEOMIN (Biological) $758.53
- Humira (Biological) $299.92
- Xeomin (Biological) $263.23
- Prolia (Biological) $252.77
- OPZELURA (Drug) $225.71
- HUMIRA (Biological) $215.00
- Victoza (Drug) $196.05
- TALTZ (Drug) $192.88
- Tresiba (Drug) $192.77
- JARDIANCE (Drug) $186.99
- Tremfya (Drug) $179.66
- DUPIXENT (Biological) $171.00
- SKYRIZI (Biological) $137.13
- ILUMYA (Biological) $120.56
- Ozempic (Drug) $114.27
- BELSOMRA (Drug) $106.34
- EUCRISA (Drug) $101.80
- ANORO ELLIPTA (Drug) $95.49
- Repatha (Biological) $92.18
- SUBLOCADE (Drug) $89.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Walton
Melissa Larson, M.d, M.D
Family Medicine — Payments: $4,146
Family Medicine $4,146
Anne Donovan, M.d, M.D
Family Medicine — Payments: $1,976
Family Medicine $1,976
Nancy Shupe, M.d, M.D
Family Medicine — Payments: $853.40
Family Medicine $853.40
Joshua Kadetz, Md, MD
Family Medicine — Payments: $426.29
Family Medicine $426.29
Dr. Michael Freeman, Do, DO
Family Medicine — Payments: $403.38
Family Medicine $403.38
Jordan Mathews, Md, MD
Family Medicine — Payments: $121.36
Family Medicine $121.36